Carregant...
Chemotherapy for advanced, recurrent or metastatic endometrial carcinoma
BACKGROUND: Although endometrial adenocarcinoma is a common gynaecological cancer, a comparatively small proportion of patients present with, or develop, recurrent or advanced disease. However, for those women whose disease does progress or recur the prognosis is poor and the best treatment is yet t...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2012
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7104534/ https://ncbi.nlm.nih.gov/pubmed/22895938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003915.pub4 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|